KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019)

Aquestive Therapeutics (AQST) has 2 years of Amortizatization of Intangibles data on record, last reported at $13000.0 in Q3 2019.

  • For Q3 2019, Amortizatization of Intangibles fell 83.12% year-over-year to $13000.0; the TTM value through Sep 2019 reached -$13000.0, changed N/A, while the annual FY2018 figure was $50000.0, 1.96% down from the prior year.
  • Amortizatization of Intangibles reached $13000.0 in Q3 2019 per AQST's latest filing, roughly flat from $13000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $77000.0 in Q3 2018 and bottomed at -$52000.0 in Q4 2018.